Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: BeiGene USA, Inc
Woman and Man Max 99 years
BeiGene USA, Inc
Update Il y a 4 ans
A Phase 3, Randomized, Open-Label, Multicenter Study Comparing the Efficacy and Safety of the medications BGB-3111 and Ibrutinib in Subjects with Waldenström’s Macroglobulinemia (WM) Estudio de Fase 3, abierto, aleatorizado y multicéntrico, para comparar la eficacia y la seguridad de BGB-3111 frente al ibrutinib, en sujetos con macroglobulinemia de Waldenström (WM)
To evaluate the efficacy of BGB-3111 vs ibrutinib in subjects with MYD88MUT WM Evaluar la eficacia del BGB-3111 frente al ibrutinib en sujetos con WM - MYD88MUT
Country
None
organs
None
Specialty
None
unknown
More information